Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Destabilization of Microtubules01:45

Destabilization of Microtubules

3.5K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
3.5K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

3.7K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.7K
Cancer Prevention02:59

Cancer Prevention

7.7K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.7K
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

1.3K
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.3K
Preventive Healthcare Services01:30

Preventive Healthcare Services

1.9K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.9K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

3.5K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: In situ cryo-ET defines the ultrastructure of ER exit sites in human cells.

Nature cell biology·2026
Same author

Chromosomal Instability: A Potential Biomarker of Radiation Response.

Radiation research·2026
Same author

In situ cryo-ET defines the ultrastructure of ER exit sites in human cells.

Nature cell biology·2026
Same author

Mad1 facilitates α5 integrin trafficking from the Golgi to promote abscission during cytokinesis.

Nature communications·2026
Same author

Pretreatment Chromosomal Instability Correlates With Radiation Sensitivity in Squamous Cell Cancers.

International journal of radiation oncology, biology, physics·2026
Same author

A live tumor fragment platform to assess immunotherapy response in core needle biopsies while addressing challenges of tumor heterogeneity.

Journal of translational medicine·2026

Related Experiment Video

Updated: Jan 26, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

10.0K

Mad1 destabilizes p53 by preventing PML from sequestering MDM2.

Jun Wan1, Samuel Block2, Christina M Scribano1

  • 1Department of Cell and Regenerative Biology, University of Wisconsin-Madison, Madison, WI, 53705, USA.

Nature Communications
|April 6, 2019
PubMed
Summary

Upregulated Mitotic Arrest Deficient 1 (Mad1) promotes breast cancer by preventing tumor suppressor p53 stabilization. Mad1 interacts with PML bodies, displacing MDM2 and leading to p53 degradation.

More Related Videos

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

2.7K
Isolation and Analysis of Brain-sequestered Leukocytes from Plasmodium berghei ANKA-infected Mice
12:48

Isolation and Analysis of Brain-sequestered Leukocytes from Plasmodium berghei ANKA-infected Mice

Published on: January 2, 2013

13.2K

Related Experiment Videos

Last Updated: Jan 26, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

10.0K
Purification of Ubiquitinated p53 Proteins from Mammalian Cells
10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

2.7K
Isolation and Analysis of Brain-sequestered Leukocytes from Plasmodium berghei ANKA-infected Mice
12:48

Isolation and Analysis of Brain-sequestered Leukocytes from Plasmodium berghei ANKA-infected Mice

Published on: January 2, 2013

13.2K

Area of Science:

  • Cell Biology
  • Cancer Research
  • Molecular Oncology

Background:

  • Mitotic Arrest Deficient 1 (Mad1) is known for its role in the mitotic checkpoint.
  • Interphase functions of Mad1, independent of the mitotic checkpoint, are largely unknown.
  • Mad1 upregulation is frequently observed in human breast cancers.

Purpose of the Study:

  • To investigate the uncharacterized interphase roles of Mad1 in cancer.
  • To determine how Mad1 upregulation affects tumor suppressor p53 stability.
  • To elucidate the molecular mechanisms underlying Mad1's function in breast cancer.

Main Methods:

  • Investigated Mad1 localization in breast cancer and cultured cells using immunofluorescence.
  • Performed co-immunoprecipitation assays to study Mad1-PML and PML-MDM2 interactions.
  • Utilized cell-based assays to assess p53 stabilization and ubiquitination.
  • Generated orthotopic mammary tumor models to evaluate tumor growth in vivo.

Main Results:

  • Upregulated Mad1 prevents stress-induced stabilization of the tumor suppressor p53.
  • Mad1 localizes to ProMyelocytic Leukemia (PML) nuclear bodies and interacts with PML, an interaction enhanced by sumoylation.
  • Mad1 displaces MDM2 from PML, leading to increased p53 ubiquitination and degradation.
  • Mad1 upregulation accelerates mammary tumor growth and reduces p53 and p21 levels.

Conclusions:

  • Mad1 has an unexpected interphase role in promoting tumors.
  • Mad1 destabilizes p53 by interfering with the PML-MDM2 complex.
  • Mad1 upregulation contributes to breast cancer progression through p53 pathway inhibition.